跨領域 › 支持療護
血液疾病的疼痛處置
Pain Management in Hematology
概覽
Buzzwords → Dx
| Pain Type | Drugs / Approach |
|---|---|
| Mild | Acetaminophen + NSAID (caution renal, plt <50, GI) |
| Moderate | Codeine, tramadol, low-dose oxycodone or hydromorphone |
| Severe / chronic cancer | Long-acting morphine / oxycodone / hydromorphone / fentanyl patch + breakthrough short-acting q4h prn |
| VOC pain (SCD) | IV opioid PCA: morphine or hydromorphone; goal pain control + IVF |
| Neuropathic pain | Gabapentin, pregabalin, duloxetine, nortriptyline |
| Bone pain (MM, bone met) | Bisphosphonates / denosumab + opioids + radiation; consider radium-223 (prostate met) |
| Breakthrough pain | Short-acting opioid 10-20 % of total daily dose; titrate |
| Fentanyl patch | Long-acting transdermal; 25 mcg/h ≈ ~50 mg morphine PO/d |
| Methadone | Long-acting; NMDA + opioid; QT prolongation; complex conversion |
| Ketamine | Adjunct for opioid-resistant pain |
| AVOID meperidine | Norverbal accumulates → seizures, esp. renal failure or chronic use |
| Gabapentinoids + opioids | Synergistic respiratory depression — caution |
| Opioid-induced constipation | Universal ppx with stimulant laxative + osmotic |
| Opioid hyperalgesia | Paradoxical ↑pain with high-dose; rotate opioid + ↓dose |
| Opioid use disorder (OUD) screening | Cancer survivors, SCD; balance under-treatment vs OUD risk |
分類與診斷
Workup
- Pain assessment: location, character, intensity (VAS/NRS), temporal, radiation, alleviating/exacerbating, functional impact.
- History: prior opioid use, OUD risk, allergies, comorbidities (renal, hepatic, GI, respiratory).
- Labs: BMP, LFTs (drug metabolism + dose adjustment).
治療
Treatment Algorithm
flowchart TD
A[Pain assessment] --> B{Severity + type}
B -- mild --> C[Acetaminophen + NSAID<br>± adjuvants per type]
B -- moderate --> D[+ Weak opioid (codeine, tramadol)<br>or low-dose oxycodone / hydromorphone]
B -- severe / chronic cancer --> E[Long-acting opioid + breakthrough<br>+ adjuvants for neuropathic / bone]
B -- SCD VOC --> F[IV opioid PCA<br>+ IVF + warmth + spirometry<br>NOT meperidine]
B -- neuropathic --> G[Gabapentin / pregabalin / duloxetine / TCAs<br>± opioid]
B -- bone pain --> H[Bisphosphonate / denosumab + RT + opioid<br>radium-223 for prostate met]
C --> I[Constipation prophylaxis stimulant + osmotic]
D --> I
E --> I
F --> I
G --> I
H --> I
I --> J{Adequate control?}
J -- no --> K[Rotate opioid<br>methadone consult<br>regional anesthesia / nerve block<br>palliative care]
陷阱與考點
Pearls / Pitfalls
- Avoid meperidine in chronic pain or renal failure — norverbal metabolite accumulates → seizures, dysphoria.
- Codeine is a prodrug (CYP2D6 → morphine); ultra-rapid metabolizers can have toxicity at standard doses; poor metabolizers ineffective. Avoid in children for tonsillectomy/adenoidectomy (FDA).
- Tramadol has serotonergic + opioid effects → SS risk with SSRIs; seizure risk; lower opioid-equivalent.
- Methadone has long, variable half-life + QT prolongation — use specialist guidance.
- Fentanyl patch onset is slow (12–18 h) + lasts 72 h — NOT for acute pain control.
- Buprenorphine + naloxone (Suboxone) for opioid use disorder — partial mu agonist; can complicate pain management; involve OUD specialist.
- NSAIDs caution: avoid in plt <50, active bleeding, CKD, peptic ulcer disease, recent GI bleed.
- Acetaminophen max 3 g/d (chronic) or 4 g/d (short-term); reduce in liver disease.
- Opioid-induced constipation is universal — start stimulant laxative (senna) + osmotic (polyethylene glycol) prophylactically.
- Opioid-induced respiratory depression treated with naloxone — short half-life (30–90 min) so re-dosing or infusion required for long-acting opioid overdose.
- Adjuvants for neuropathic pain: gabapentin / pregabalin (titrate slowly, sedation), duloxetine (also depression), nortriptyline (anticholinergic).
- Bone pain in MM: bisphosphonate (zoledronic acid / pamidronate) or denosumab + opioids + radiation; reduces fractures + pain.
- Cancer pain: undertreatment is common — assess + titrate aggressively. Most cancer pain is opioid-responsive; switch routes (IV → SC → PO) as functional status changes.
- Palliative care consultation for refractory pain, complex symptom management, psychosocial issues, end-of-life planning.
- SCD chronic pain: balance VOC management + chronic pain management; opioid stewardship critical with hydroxyurea / disease-modifying therapies.
延伸
Cross-references
- SCD VOC — opioid PCA
- MM — bone pain + bisphosphonates
- Cord compression — pain + dexamethasone
- Opioid-induced nausea
- Drug Regimens — opioids, adjuvants, chelators
相關題目
- Q-211 — Avoid meperidine in chronic pain
- Q-212 — Bone pain in MM — multimodal management
- Q-213 — Methadone — opioid rotation
來源
Sources
Footnotes
-
World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. 2018. ↩
-
Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Advances 2020;4(12):2656–2701. doi:10.1182/bloodadvances.2020001851. ↩